Abstract
Purpose
The aim of this investigation was to formulate and evaluate naproxen transethosomal gel for sustained transdermal delivery for the management of musculoskeletal pain.
Methods
In this examination naproxen sodium-loaded transethosomes were developed by ethanol injection method. A 9 run, 2-factor, 3-level factorial design was used to optimize naproxen-transethosomes. Transethosomal formulations were then incorporated into hydrogel made of gelling agent carbopol 940. The formulated transethosomes were characterized for particle size, entrapment efficiency, zeta potential, in-vitro release, ex-vivo drug permeation study, drug deposition study, and in-vivo anti-inflammatory study.
Results
The results exhibited that the particle size were in the range of 56.94 ± 0.12 nm to 291.7 ± 0.09 nm. The transethosomes had higher entrapment efficiency in between 66.23 ± 1.52 and 93.11 ± 0.96% and exhibited a spherical morphology when examined by TEM analysis. The in-vitro skin permeation study carried out on rat skin exhibited enhanced skin deposition with lesser systemic absorption. The in-vivo studies carried out on rats showed the superiority of naproxen transethosomal gel in reducing the edema rate.
Conclusion
The results obtained all together demonstrated that the formulated transethosomal gel possessed a smaller particle size, high entrapment efficiency along higher skin deposition rate which is required in getting relief from musculoskeletal pain. The developed formulation could be regarded as an ideal substitute for the conventional gel for the management of musculoskeletal pain.
Similar content being viewed by others
References
Abdelbary AA, Aboughaly MHH (2015) Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485:235–243
Abdulbaqi IM, Darwis Y, Khan NA, Assi RA, Khan AA (2016) Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomed 25:2279–2304
Albash R, Abdelbary AA, Refai H, El-Nabarawi MA (2019) Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Int J Nanomed 14:1953–1968
Al-Mahallawi AM, Khowessah OM, Shoukri RA (2014) Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm 472:304–314
Al-Shuwaili AH, Rasool BKA, Abdulrasool AA (2016) Optimization of elastic Transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm 102:101–114
Andega S, Kanikkannan N, Singh M (2001) Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release 77:17–25
Aranya M, Pensak J, Narinthorn K, Worapaka JM (2009) Novel elastic nanovesicles for cosmeceutical and pharmaceutical applications. Chiang Mai J Sci 36:168–178
Ascenso A, Raposo S, Batista C, Cardoso P, Mendes T et al (2015) Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomed 10:5837–5851
Azizah N, Sagita E, Iskandarsyah (2017) In vitro penetration tests of transethosome gel preparations containing capsaicin. Int J Appl Pharm 9:116–119
Bhatt P, Narvekar P, Lalani R, Chougule MB, Pathak Y, Sutariya V (2019) An in vitro assessment of thermo-reversible gel formulation containing sunitinib nanoparticles for neovascular age-related macular degeneration. AAPS PharmSciTech 20:281
Bolzinger M, Briançon S, Pelletier J, Chevalier Y (2012) Penetration of drugs through skin, a complex rate-controlling membrane. Curr Opin Colloid Interface Sci 17:156–165
Cevc G (1996) Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carr Syst 13:257–288
Chen M, Liu X, Fahr A (2011) Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: in vitro study with finite and infinite dosage application. Int J Pharm 408:223–234
Chen J, Lu WL, Gu W, Lu SS, Chen ZP, Cai BC (2013) Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv 10:845–856
Chen ZX, Li B, Liu T, Wang X (2017) Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J Pharm Sci 99:240–245
Chow LH, Chen YH, Wu WC, Chang EP, Huang EYK (2016) Sex difference in oxytocin- induced anti-hyperalgesia at the spinal level in rats with intraplantar carrageenan-induced inflammation. PLoS ONE 11:1–15
Dhawale T, Kumar S, Dharmadhikari S (2019) Evaluation of analgesic and anti-inflammatory activity of ibuprofen and duloxetine in animal models. Natl J Physiol Pharm Pharmacol 9:842–846
Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T (2013) Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers. AAPS PharmSciTech 14:133–140
El-Alim SA, Kassem A, Basha M, Salama A (2019) Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int J Pharm 563:293–303
El-Menshawe SF, Kharshoum RM, El-Sisi AM (2017) Preparation and optimization of buccal propranolol hydrochloride nanoethosomal gel: a novel approach for enhancement of bioavailability. J Nanomed Nanotechnol 8:435–444
Elsayed MS, Abdallah OY, Nagar VF (2006) Deformable liposomes and ethosomes, mechanism of enhanced skin delivery. Int J Pharma 322:60–66
El-Zaafarany GM, Awad GAS, Holayel SM, Mortada ND (2010) Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–172
Ghanbarzadeh S, Arami S (2013) Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersome. BioMed Res Int. https://doi.org/10.1155/2013/616810
Gondkar SB, Patil NR, Saudagar RB (2017) Formulation development and characterization of drug loaded transethosomes for transdermal delivery: review article. Int J ChemTech Res 10:534–544
Gupta A, Aggarwal G, Singla S, Arora R (2012) Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation. Sci Pharm 80:1061–1080
Hiruta Y, Hattori Y, Kawano K, Obata Y, Maitani Y (2006) Novel ultradeformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release 113:146–154
Honeywell-Nguyen PL, Bouwstra JA (2003) The in vitro transport of pergolide from surfactant based elastic vesicles through human skin: a suggested mechanism of action. J Control Release 86:145–156
Ibrahim MA, Yusrida D, Reem AA, Nurzalina AKK (2018) Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug Des Devel Ther 12:795–813
Jain S, Jain P, Umamaheshwari RB, Jain NK (2003) Transfersomes—a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013–1026
Jain S, Tiwary AK, Sapra B, Jain NK (2007) Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8:111–119
Jepps OG, Dancik Y, Anissimov YG, Roberts MS (2013) Modeling the human skin barrier–towards a better understanding of dermal absorption. Adv Drug Deliv Rev 65:152–168
Kaul S, Gulati N, Verma D, Mukherjee S, Nagaich U (2018) Role of nanotechnology in cosmeceuticals: a review of recent advances. J Pharm. https://doi.org/10.1155/2018/3420204
Kaul S, Jain N, Pandey J, Nagaich U (2020) Investigating the retention potential of chitosan nanoparticulate gel: design, development, in vitro & ex vivo characterization. Recent Pat Antiinfect Drug Discov 15:41–67
Kumar L, Utreja P (2020) Formulation and characterization of transethosomes for enhanced transdermal delivery of propranolol hydrochloride. Micro Nanosyst 12:38–47
Kumar A, Pathak K, Bali V (2012) Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today 17:1233–1241
Kumar L, Verma S, Singh K, Prasad DN, Jain AK (2016) Ethanol based vesicular carriers in transdermal drug delivery: nanoethosomes and transethosomes in focus. NanoWorld J 2:41–51
Lei M, Wang J, Ma M, Yu M, Tan F, Li N (2015) Dual drug encapsulation in a novel nano-vesicular carrier for the treatment of cutaneous melanoma: characterization and in vitro/in vivo evaluation. RSC Adv 5:20467–20478
Lerma HC, María EMB, Mónica MVA, Juan VCR, José MC et al (2021) Segmented poly(urea)urethane nanoparticles: size optimization using Taguchi experimental design and nanoprecipitation method. Curr Nanosci 17:70–80
Li G, Fan Y, Fan C, Li X, Wang X et al (2012) Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm 82:49–57
López-Pinto JM, González-Rodríguez ML, Rabasco AM (2005) Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1–12
Ma M, Wang J, Guo F, Lei M, Tan F (2015) Development of Nano vesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation. J Mater Sci Mater Med 26:191–202
Moolakkadath T, Aqil M, Ahad A, Imam SS, Iqbal B et al (2018) Development of transethosomes formulation for dermal fisetin delivery: Box-Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies. Artif Cells Nanomed Biotechnol 46:755–765
Ramadon D, Anwar E, Harahap Y (2017) In vitro penetration and bioavailability of novel transdermal quercetin-loaded ethosomal gel. Indian J Pharm Sci 79:948–956
Ricci M, Giovagnoli S, Blasi P, Schoubben A, Perioli L, Rossi C (2006) Development of liposomal capreomycin sulfate formulations: effects of formulation variables on peptide encapsulation. Int J Pharm 311:172–181
Romero EL, Morilla MJ (2013) Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations. Int J Nanomed 8:3171–3186
Rottke M, Lunter DJ, Daniels R (2014) In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions. Eur J Pharm Biopharm 86:260–266
Sarwa KK, Mazumder B, Rudrapal M, Verma VK (2015) Potential of capsaicin-loaded transfersomes in arthritic rats. Drug Deliv 22:638–646
Shaji J, Bajaj R (2017) Formulation development of 5-fluorouracil transethosomes for skin cancer therapy. Int J Pharm Pharm 11:453–464
Shaji J, Garude S (2014) Transethosomes and ethosomes for enhanced transdermal delivery of ketorolac tromethamine: a comparative assessment. Int J Curr Pharm Res 6:88–93
Shariat A, Tamrin SBM, Arumugam M, Danaee M, Ramasamy R (2016) Office exercise training to reduce and prevent the occurrence of musculoskeletal disorders among office workers: a hypothesis. Malays J Med Sci 23:54–58
Singh HP, Utreja P, Tiwary AK, Jain S (2009) Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J 11:54–64
Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD (2012) A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B 92:299–304
Tambade SA, Aloorkar NH, Dabane NS, Osmani RM, Kale BB, Indalka YR (2014) Formulation and evaluation of novel gel containing liquid crystals of naproxen. Am J Adv Drug Deliv 2:364–386
Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–418
Vanić Ž, Hafner A, Bego M, Škalko-Basnet N (2013) Characterization of various deformable liposomes with metronidazole. Drug Dev Ind Pharm 39:481–488
Varun G, Harmanpreet S, Amit B, Kaisar R, Sachin KS et al (2017) Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS PharmSciTech 18:58–71
Verma S, Utreja P (2018) Transethosomes of econazole nitrate for transdermal delivery: development, in-vitro characterization, and ex-vivo assessment. Pharm Nanotechnol 6:171–179
Vinod KR, Kumar MS, Anbazhagan S, Sandhya S, Saikumar P et al (2012) Critical issues related to transfersomes - novel vesicular system. Acta Sci Pol Technol Aliment 11:67–82
Wallace SJ, Li J, Nation RL, Boyd BJ (2012) Drug release from nanomedicines: selection of appropriate encapsulation and release methodology. Drug Deliv Transl Res 2:284–292
Wright A, Sluka KA (2001) Nonpharmacological treatments for musculoskeletal pain. Clin J Pain 17:33–46
Zeb A, Qureshi OS, Kim HS, Cha JH, Kim JK (2016) Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine 11:3813–3824
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors (S. Kaul, N. Jain, and U. Nagaich) declare no conflicts of interest.
Statement of human and animal rights
The study was reviewed and approved by the Institutional Animal Ethical Committee with registration number 1327/PO/ ReBi/S/10 /CPCSEA. All institutional and national guidelines for the care and use of laboratory animals were followed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kaul, S., Jain, N. & Nagaich, U. Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain. J. Pharm. Investig. 52, 217–231 (2022). https://doi.org/10.1007/s40005-021-00555-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-021-00555-7